US life sciences business acquires Dublin-headquartered biotech company ValitaCell.

Prior to the transaction, laboratory automation and technology company Beckman Coulter Life Sciences had a long-standing partnership with ValitaCell. Beckman Coulter Life Sciences is now purchasing the Irish start-up to expand its offering.

With the goal of cutting the price and time to market for innovative treatments, ValitaCell develops analytical technology and products for the biopharmaceutical industry.

It has a second facility in Galway and its main office is at the National Institute of Bioprocessing Research and Training in Dublin.

The company has won numerous awards, including Irish Pharma Start-up of the Year in 2017 and first place at InterTrade Ireland’s Seedcorn Awards in 2016. Its technologies are patented in a number of international markets.

The EU’s Horizon 2020 program helped the start-up, which was established in 2014, by providing €2 million in funding in 2017.

We use cookies to give you the best online experience. By agreeing you consent the use of cookies in accordance with our Privacy Statement and cookie settings in your Privacy Settings below.

Privacy Settings saved!
Privacy Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie

Decline all Services
Accept all Services